Hydrates and helps restore your skin’s barrier function and balance.
Appropriate for dry or post-procedure skin.
Store at room temperature 15° – 30°C (59° – 86°F).
Key Benefits of TNS
Ceramide Treatment Cream™
Hydrates and helps restore skin’s moisture balance
Restores skin’s moisture barrier
This product contains TNS®, peptides and a patented Ceramide technology to hydrate and help restore your skin’s natural barrier function.
Human Fibroblast Conditioned Media (TNS®):
A physiologically balanced, naturally secreted and stabilized combination of multiple natural messenger proteins.
Hydroxypropyl Bispalmitamide MEA (Ceramide):
Skin barrier agent that helps promote and maintain the moisture mantle of the skin and enhances the skin texture.
A synthetic tripeptide designed to help reduce the appearance of fine lines and wrinkles.
A synthetic peptide designed to help reduce the appearance of fine lines and wrinkles.
Water/Aqua/Eau, Cetyl Ethylhexanoate, Cetearyl Alcohol, Hydroxypropyl Bispalmitamide MEA, Human Fibroblast Conditioned Media, Dimethicone, Olea Europaea (Olive) Fruit Oil, Glycine Soja (Soybean) Oil, Glycerin, Cetearyl Glucoside, Squalane, Glyceryl Stearate, PEG-100 Stearate, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Tetrahexyldecyl Ascorbate, Avena Sativa (Oat) Kernel Extract, Glycine Soja (Soybean) Sterols, Retinyl Palmitate, Tocopheryl Acetate, Sodium Carboxymethyl Beta-Glucan, Allantoin, Bisabolol, Panthenol, Sodium Hyaluronate, Xanthan Gum, Polysorbate 20, Isoceteth-20, Butylene Glycol, Ethoxydiglycol, Carbomer, Disodium EDTA, Ethylhexylglycerin, Phenoxyethanol, Caprylyl Glycol, Caprylhydroxamic Acid, Potassium Sorbate
How long to use?
After procedures, it’s best to consult your physician, but generally TNS Ceramide Treatment Cream™ can be used morning and night. If you are using TNS Ceramide Treatment Cream as a daily part of your skin care regimen there is no limit to the amount of applications.
What is TNS®?
A mixture of human growth factors, cytokines, antioxidants and matrix proteins.
What are growth factors?
Growth factors are inherent in our bodies and play a role in maintaining skin.
CAUTION: Do not use Retinol Complex if you are pregnant, lactating, or planning to become pregnant. Mild redness, peeling, and irritation are expected when using these products. Use a sunscreen and limit sun exposure while using these products, and for a week following discontinuation.
CAUTION: GlyPro products used together may cause irritation.
Sunburn alert: AHA/BHA Exfoliating Cleanser, AHA/BHA Cream, and all GlyPro products contain an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using these products, and for a week following discontinuation.
IMPORTANT! SUNSCREEN IS REQUIRED TO OPTIMIZE AND MAINTAIN THE RESULTS OF USING LYTERA® 2.0 PIGMENT CORRECTING SERUM.
Most SkinMedica® products are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA, and the statements have not been evaluated by the FDA.
SkinMedica® TOTAL DEFENSE + REPAIR Broad Spectrum Sunscreens (SPF 34, SPF 34 Tinted, and SPF 50+) and Essential Defense Broad Spectrum Sunscreens (Everyday Clear SPF 47, Mineral Shield Tinted SPF 32, and Mineral Shield SPF 35) are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 352.
The PA rating system is used in Japan to classify UVA protection and is not an FDA requirement on sunscreens sold in the U.S.
SkinMedica® Acne System, Acne Treatment Lotion, Purifying Foaming Wash, and Purifying Toner are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 333 Subpart D.
Not all products are available in Canada. Subject to change at any time without prior notice.